2013
DOI: 10.1016/j.reprotox.2013.07.019
|View full text |Cite
|
Sign up to set email alerts
|

Valproic acid and its derivatives enhanced estrogenic activity but not androgenic activity in a structure dependent manner

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
6
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(6 citation statements)
references
References 63 publications
0
6
0
Order By: Relevance
“…Our findings differ slightly in the sense that in WWE with menstrual disorders, VPA was associated with higher estradiol levels, while lamotrigine was associated with lower FSH levels. An in-vitro study demonstrated that VPA directly inhibits ovarian steroid production, namely FSH and estradiol synthesis ( 31 ); however, other studies show that VPA tends to increase estradiol activity, either through inhibition of liver enzymes or enhancement of estrogen receptors ( 32 ). Lower FSH levels have also been discovered in patients who underwent monotherapy with lamotrigine, regardless of their menstrual phase ( 33 ).…”
Section: Discussionmentioning
confidence: 99%
“…Our findings differ slightly in the sense that in WWE with menstrual disorders, VPA was associated with higher estradiol levels, while lamotrigine was associated with lower FSH levels. An in-vitro study demonstrated that VPA directly inhibits ovarian steroid production, namely FSH and estradiol synthesis ( 31 ); however, other studies show that VPA tends to increase estradiol activity, either through inhibition of liver enzymes or enhancement of estrogen receptors ( 32 ). Lower FSH levels have also been discovered in patients who underwent monotherapy with lamotrigine, regardless of their menstrual phase ( 33 ).…”
Section: Discussionmentioning
confidence: 99%
“…Indeed, this compound can be metabolized into a fatty acid‐CoA complex and then enters the Krebs's cycle for energy production in mitochondria (FCT, ; Federal Register, ). Nevertheless, as recently shown by Stempin et al, () using in vitro experiments, derivatives of short‐chain fatty acids such as 2‐(2‐propynyl)‐nonanoic acid (a derivative of valproic acid with pelargonic acid) could activate the estrogen receptor α (ERα) in stably transfected human cell line (HEK293). Moreover, there may be several ways in which xenobiotics, including nonsteroidogenic chemicals, could interact with the endocrine and reproductive systems of vertebrates, i.e., not only through direct interactions with nuclear receptors but also through modulation of metabolizing enzyme activities, or interferences with hormone binding serum proteins and other nongenomic pathways (Foradori et al, ; De Coster and van Larebeke, ).…”
Section: Discussionmentioning
confidence: 94%
“…Remarkably, we demonstrated that this approach can be used to identify chemicals that alter endocrine-related functions driving ovary development. estrogenic activity 37 8.9 × 10 −34 steroidogenic effect 38…”
Section: ■ Discussionmentioning
confidence: 99%